Latest Moderna News and Updates : Moderna updates, Moderna News , Moderna around the world

Nishadil

Washington | 20°C (light rain)

A President's Pledge: RFK Jr. Vows to Revoke All COVID-19 Emergency Use Authorizations

Top story

A President's Pledge: RFK Jr. Vows to Revoke All COVID-19 Emergency Use Authorizations

In focus

Latest feed

Market Mavericks and Movers: A Tuesday Snapshot

A New Chapter in Flu Prevention: Moderna's mRNA Vaccine Nears FDA Approval

Wall Street's Latest Chapter: Navigating Gains and Underlying Sentiment

A Beacon of Hope: Personalized mRNA Vaccine Targets Pancreatic Cancer Recurrence

Latest headlines

A New Frontier in Cancer Treatment: The Promise of mRNA Vaccines

A New Frontier in Cancer Treatment: The Promise of mRNA Vaccines

A Game-Changer for Public Health: EMA Backs Moderna's Combined COVID-Flu Vaccine

A Game-Changer for Public Health: EMA Backs Moderna's Combined COVID-Flu Vaccine

The Early Birds: What's Stirring the Stock Market Before the Open?

The Early Birds: What's Stirring the Stock Market Before the Open?

Wall Street's Jitters: Inflation Fears and Shifting Fortunes for Key Stocks

Wall Street's Jitters: Inflation Fears and Shifting Fortunes for Key Stocks

A Slower Lane for Innovation? FDA Opts for Standard Review of Moderna's mRNA Flu Shot

A Slower Lane for Innovation? FDA Opts for Standard Review of Moderna's mRNA Flu Shot

Moderna's Ambitious mRNA Flu Vaccine Hits a Regulatory Snag

Moderna's Ambitious mRNA Flu Vaccine Hits a Regulatory Snag

A Regulatory Stumble: FDA Puts Brakes on Moderna's Flu Vaccine Hopes

A Regulatory Stumble: FDA Puts Brakes on Moderna's Flu Vaccine Hopes

A Setback for Moderna's mRNA Flu Vaccine Aspirations

A Setback for Moderna's mRNA Flu Vaccine Aspirations

A Bumpy Road Ahead? FDA Hits Pause on Moderna's Flu Shot Application

A Bumpy Road Ahead? FDA Hits Pause on Moderna's Flu Shot Application

A New Era for Flu Protection? Moderna's mRNA Vaccine on the Horizon

A New Era for Flu Protection? Moderna's mRNA Vaccine on the Horizon

Moderna's Big Turnaround: Why Jim Cramer is Eyeing 2026 for Revenue Growth

Moderna's Big Turnaround: Why Jim Cramer is Eyeing 2026 for Revenue Growth

The Shifting Sands of Pharma: Innovation, Access, and Lingering Questions in Early 2026

The Shifting Sands of Pharma: Innovation, Access, and Lingering Questions in Early 2026

The Bear Trap? Goldman Sachs Flags Big-Name Stocks with Soaring Short Interest

The Bear Trap? Goldman Sachs Flags Big-Name Stocks with Soaring Short Interest

Following the Smart Money: Decoding This Week's Insider Trading Signals

Following the Smart Money: Decoding This Week's Insider Trading Signals

The Biotech Rollercoaster: Moderna Defies Gravity with a Q3 Power Play

The Biotech Rollercoaster: Moderna Defies Gravity with a Q3 Power Play

From Pandemic Frontlines to Harvard's Hallowed Halls: The Unfolding Legacy of Dr. Kizzmekia Corbett

From Pandemic Frontlines to Harvard's Hallowed Halls: The Unfolding Legacy of Dr. Kizzmekia Corbett

October's Unfolding Story: mRNA Flu Shots, Mental Health's New Front, and Shifting Sands in Healthcare

October's Unfolding Story: mRNA Flu Shots, Mental Health's New Front, and Shifting Sands in Healthcare

The Great Biotech Reckoning: Moderna's Wild Ride from Pandemic Hero to Post-COVID Crossroads

The Great Biotech Reckoning: Moderna's Wild Ride from Pandemic Hero to Post-COVID Crossroads

Could the Messenger Hold the Key? mRNA's Daring Leap from Viruses to Tumors

Could the Messenger Hold the Key? mRNA's Daring Leap from Viruses to Tumors

The Ongoing Vigil: Singapore Strengthens Defenses with Next-Gen COVID-19 Vaccines

The Ongoing Vigil: Singapore Strengthens Defenses with Next-Gen COVID-19 Vaccines

Beyond the Pandemic: Moderna's Ambitious Bet on mRNA as the Next Big Cancer Weapon

Beyond the Pandemic: Moderna's Ambitious Bet on mRNA as the Next Big Cancer Weapon

A Major Setback: Moderna's Highly Anticipated CMV Vaccine Fails Key Efficacy Goal in Phase 3

A Major Setback: Moderna's Highly Anticipated CMV Vaccine Fails Key Efficacy Goal in Phase 3

Alberta's Vaccination Drive Accelerates: Second Phase of COVID-19 Bookings Now Open

Alberta's Vaccination Drive Accelerates: Second Phase of COVID-19 Bookings Now Open

Beyond Vaccines: Moderna Co-Founder Warns of Widespread Attacks on Science

Beyond Vaccines: Moderna Co-Founder Warns of Widespread Attacks on Science

Get Protected: Updated COVID-19 Vaccines Now Widely Available Without a Prescription!

Get Protected: Updated COVID-19 Vaccines Now Widely Available Without a Prescription!

The Dawn of Personalized Cancer Vaccines: A Glimmer of Hope in the Fight Against Melanoma

The Dawn of Personalized Cancer Vaccines: A Glimmer of Hope in the Fight Against Melanoma

Patent Peace Declared: Moderna and Alnylam End High-Stakes COVID Vaccine Tech Battle

Patent Peace Declared: Moderna and Alnylam End High-Stakes COVID Vaccine Tech Battle

Healthcare Shorts Take a Breather, But Moderna Remains Under the Microscope

Healthcare Shorts Take a Breather, But Moderna Remains Under the Microscope

Pharma Giants Stumble: CDC Plan to Add COVID-19 Vaccines to Childhood Schedule Sparks Market Jitters

Pharma Giants Stumble: CDC Plan to Add COVID-19 Vaccines to Childhood Schedule Sparks Market Jitters

Carisma Therapeutics Shares Soar Over 130% on Groundbreaking Moderna Collaboration for In Vivo CAR-M Therapies

Carisma Therapeutics Shares Soar Over 130% on Groundbreaking Moderna Collaboration for In Vivo CAR-M Therapies

Trump Unleashes Scathing Critique on Pharma Giants Over COVID-19 Vaccines and Profits

Trump Unleashes Scathing Critique on Pharma Giants Over COVID-19 Vaccines and Profits

Crucial Update: FDA Greenlights Enhanced COVID-19 Vaccines for At-Risk Communities

Crucial Update: FDA Greenlights Enhanced COVID-19 Vaccines for At-Risk Communities

The Waiting Game: Why Your Updated COVID Vaccine Might Be Hard to Find

The Waiting Game: Why Your Updated COVID Vaccine Might Be Hard to Find

Your Essential Guide to the Latest COVID-19 Vaccines: Eligibility and Recommendations in the US

Your Essential Guide to the Latest COVID-19 Vaccines: Eligibility and Recommendations in the US

Expert's Urgent Call: COVID-19 Remains a Serious Threat Even as New Fall Vaccines Arrive

Expert's Urgent Call: COVID-19 Remains a Serious Threat Even as New Fall Vaccines Arrive

Canada's New Line of Defense: Updated COVID-19 Vaccines Approved for Fall

Canada's New Line of Defense: Updated COVID-19 Vaccines Approved for Fall

Market Jitters: Why Analysts Are Toning Down Their Bullish Outlooks, Starting with Gap Inc.

Market Jitters: Why Analysts Are Toning Down Their Bullish Outlooks, Starting with Gap Inc.

Load more